Fundz

Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer

PRIVATEJul 27, 2026
Internal move“previously served as Strategic Advisor”

Position

Chief Executive Officer

Company

Rose Hill Life Sciences

Jama Pitman
BostonBiotechnologyHealth CareTherapeutics

Description

Rose Hill Life Sciences has announced the appointment of Jama Pitman as the new Chief Executive Officer. Pitman, who previously served as Strategic Advisor, will lead the organization in advancing its clinical programs in psychedelic therapeutics.

Quick answer

Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer (July 27, 2026). Rose Hill Life Sciences is based in Boston, Massachusetts, United States.

Who is the new Chief Executive Officer at Rose Hill Life Sciences?
Rose Hill Life Sciences named Jama Pitman Chief Executive Officer, announced July 27, 2026.
What did Rose Hill Life Sciences announce on July 27, 2026?
Rose Hill Life Sciences has announced the appointment of Jama Pitman as the new Chief Executive Officer. Pitman, who previously served as Strategic Advisor, will lead the organization in advancing its clinical programs in psychedelic therapeutics.
What does Rose Hill Life Sciences do?
Rose Hill Life Sciences is a clinical-stage biotechnology company focused on advancing psychedelic therapeutics for neurological and psychiatric conditions.
Where is Rose Hill Life Sciences based?
Rose Hill Life Sciences is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Precision BioSciences (July 27, 2026), Sarepta Therapeutics (July 27, 2026), Legend Biotech (July 27, 2026) and InstaMed Pharmaceuticals (July 27, 2026) also announced leadership changes within 45 days of Rose Hill Life Sciences.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Rose Hill Life Sciences, and when

A new leader at Rose Hill Life Sciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Rose Hill Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rose Hill Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rose Hill Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rose Hill Life Sciences

Location

Boston, Massachusetts, United States

About

Rose Hill Life Sciences is a clinical-stage biotechnology company focused on advancing psychedelic therapeutics for neurological and psychiatric conditions. The company aims to develop innovative treatments leveraging psilocybin. With a strong emphasis on clinical programs, Rose Hill is poised to impact the future of medicine in these areas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rose Hill Life Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Senior decision-maker at this company
••••••••@••••••••

See Kevin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Rose Hill Life Sciences's next move

Learn about Strategic plan

Rose Hill Life Sciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.